It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 04855cam 22009134a 4500
001 ocm53223691
003 OCoLC
005 20101115101649.0
008 031010s2004 cau b 001 0 eng
010 $a 2003063422
040 $aDLC$beng$cDLC$dMNY$dNLM$dUKM$dBAKER$dMUQ$dCRH$dBTCTA$dYDXCP$dBUR$dIG#$dAU@$dGEBAY$dOCLCQ
015 $aGBA4Z1147$2bnb
016 7 $a101213652$2DNLM
019 $a224065929
020 $a0520239458 (hbk. : alk. paper)
020 $a9780520239456 (hbk. : alk. paper)
020 $a0520246705 (pbk. : alk. paper)
020 $a9780520246706
035 $a(OCoLC)53223691$z(OCoLC)224065929
042 $apcc
050 00 $aRS100$b.G668 2004
060 00 $a2004 E-244
060 10 $aQV 736$bG659z 2004
082 00 $a338.4/3/61510973$222
100 1 $aGoozner, Merrill,$d1950-
245 14 $aThe $800 million pill :$bthe truth behind the cost of new drugs /$cMerrill Goozner.
246 3 $aEight hundred million dollar pill
260 $aBerkeley :$bUniversity of California Press,$cc2004.
300 $a297 p. ;$c24 cm.
504 $aIncludes bibliographical references (p. 281-283) and index.
505 0 $apt. 1: Biohype. The longest search ; Rare profits ; The source of the new machine -- pt. 2: Directed research. A public-private partnership ; The divorce ; Breakthrough! ; The failed crusade? -- pt. 3: Big Pharma. Me too! ; The $800 million pill ; The future of innovation.
520 $a"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket.
650 0 $aPrescription pricing.
650 0 $aDrugs$xPrices.
650 0 $aPharmaceutical industry.
650 0 $aConsumer education.
650 12 $aDrug Industry$xeconomics.
650 22 $aBiomedical Research$xeconomics.
650 22 $aDrug Therapy$xeconomics.
650 6 $aMédicaments$xPrix.
650 6 $aIndustrie pharmaceutique.
650 6 $aConsommateurs$xÉducation.
650 07 $aArzneimittelforschung.$2swd
650 07 $aForschungsausgaben.$2swd
650 07 $aArzneimittelpreis.$2swd
650 07 $aÖffentliche Förderung.$2swd
650 07 $aForschungsfinanzierung.$2swd
650 07 $aStaatliche Einrichtung.$2swd
650 07 $aPharmazeutische Industrie.$2swd
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/bios/ucal052/2003063422.html
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/ucal041/2003063422.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/description/ucal042/2003063422.html
938 $aYBP Library Services$bYANK$n2044380
938 $aBaker and Taylor$bBTCP$nBK0006277893
938 $aBaker & Taylor$bBKTY$c40.00$d40.00$i0520239458$n0004345295$sactive
938 $aIngram$bINGR$n9780520239456
952 $a53223691$zDLC$bLIBRARY OF CONGRESS$dURI$hCore$iLCC$jNLM$kDDC$nSummary$ppcc$tContents$u20101105
952 $a124234663$zBOP$bBOSTON UNIV, PAPPAS LAW LIBR$hFull$iLCC$ppcc$u20100804
952 $a124689321$zMGSOL$bPACIFIC MCGEORGE SCH OF LAW$hCore$iLCC$kDDC$ppcc$u20100714
952 $a176115330$zPUL$bPRINCETON UNIV$dURI$hFull$iLCC$kDDC$ppcc$u20100805
952 $a182876319$zXOX$bPALO ALTO RES CTR$hFull$iLCC$kDDC$ppcc$u20100718
952 $a190589311$zPAU$bUNIV OF PENNSYLVANIA$dURI$hCore$iLCC$kDDC$ppcc$u20100630
952 $a219730197$zCUY$bUNIV OF CALIFORNIA, BERKELEY$dURI$hCore$iLCC$kDDC$ppcc$u20100729
952 $a224642706$zCLS$bHARVARD UNIV, CABOT SCI LIBR$hFull batch$iLCC$kDDC$u20100710
952 $a231558543$zHMS$bHARVARD UNIV, MED SCH, COUNTWAY LIBR$hFull batch$iLCC$kDDC$u20100710
952 $a242876568$zHLS$bHARVARD UNIV, HARVARD COL LIBR$hFull batch$iLCC$kDDC$u20100713
952 $a272080232$zRCJ$bSTANFORD UNIV, ROBERT CROWN LAW LIBR$dURI$hFull OCLC member$iLCC$kDDC$u20100718
952 $a490346335$zTEU$bTEMPLE UNIV$dURI$hFull$u20100804
029 1 $aNLM$b101213652
029 1 $aYDXCP$b2044380
029 1 $aNZ1$b8031837
029 1 $aIG#$b9780520239456
029 1 $aIG#$b9780520246706
029 1 $aUNITY$b079826997
029 1 $aAU@$b000025049695
029 1 $aGEBAY$b7252172
029 1 $aUKCAM$b0520239458
994 $aZ0$bPMR
948 $hNO HOLDINGS IN PMR - 1172 OTHER HOLDINGS